RECRUITINGINTERVENTIONAL
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
About This Trial
A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.
Who May Be Eligible (Plain English)
Who May Qualify:
- Provision of signed and dated electronic willing to sign a consent form form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Age 18 or older.
- Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
- Access to smartphone and internet for participating in a technology-based intervention
- Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
- English-speaking
- Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
- No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
- Resides in the Houston Metroplex
- A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Who Should NOT Join This Trial:
- Provision of signed and dated electronic willing to sign a consent form form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Age 18 or older.
- Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
- Access to smartphone and internet for participating in a technology-based intervention
- Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
- English-speaking
- Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
- No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
- Resides in the Houston Metroplex
...See full criteria on ClinicalTrials.gov
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Provision of signed and dated electronic informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Age 18 or older.
* Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
* Access to smartphone and internet for participating in a technology-based intervention
* Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
* English-speaking
* Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
* No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
* Resides in the Houston Metroplex
* A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Exclusion Criteria:
* Provision of signed and dated electronic informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Age 18 or older.
* Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
* Access to smartphone and internet for participating in a technology-based intervention
* Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
* English-speaking
* Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
* No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
* Resides in the Houston Metroplex
* A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Treatments Being Tested
BEHAVIORAL
Goal Attainment Scaling (GAS)
Goal-setting tele-coaching and the well-studied Patient Priorities Care framework will assist participants with bothersome CIPN identify their most important health goals and scale them into specific, measurable, achievable, relevant, and time-bound (SMART) goals
Locations (1)
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States